Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: GROUP B: Group B :will receive intraperitoneal instillation of 0.5% levo-bupivacine at 2mg/kg diluted with saline to make a total of 30 ml
Intervention2: GROUP C: Group C : will receive
Sponsors
Amala Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex,between age 18 years-70years,ASA physical status 1-3,who are scheduled for laparoscopic cholecystectomy under General Anesthesia and are willing and able to give informed consent will be recruited to the trial
Exclusion criteria
Exclusion criteria: Patients were excluded if 1. they had a clinical diagnosis of acute pancreatitis 2. acute preoperative pain other than biliary colic 3. chronic pain treatment 4. anti-epileptic therapy 5. history of alcohol or drug addiction 6. severe hepatic or renal impairment 7. allergy to the study drugs 8. cognitive impairment or communication problems 9. pregnant or lactating 10. conversion to open cholecystectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hour total rescue analgesic (diclofenac +/-tramadol) consumption Timepoint: at 24 hours post operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of postoperative pain scores,Time to first requirement of rescue analgesia, time to unassisted ambulation and Tolerability of the used doses represented by the side effects.Timepoint: At 6h 12h and 24 hours post operatively | — |
Countries
India
Contacts
Public ContactDR DERLIN THOMAS
Amala Institute of Medical Sciences
Outcome results
None listed